These data support the hypothesis that geniposide-mediated inhibition of mTOR improves autophagic function and ameliorates AD-related molecular processes (Aβ accumulation) and behavioral deficits in APP/PS1 mice. This evidence concerns the gene APP and Alzheimer disease.